FINV vs. ASND
FINV (FinVolution Group) and ASND (Ascendis Pharma A/S) are both stocks. FINV operates in Credit Services (Financial Services), while ASND operates in Biotechnology (Healthcare). Over the past 5 years, FINV returned -8.01%/yr vs 10.80%/yr for ASND. At a 0.17 correlation, their price movements are largely independent.
Performance
FINV vs. ASND - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FINV achieves a -1.99% return, which is significantly lower than ASND's 11.89% return.
FINV
- 1D
- 1.90%
- 1M
- 7.35%
- YTD
- -1.99%
- 6M
- -3.83%
- 1Y
- -45.47%
- 3Y*
- 7.62%
- 5Y*
- -8.01%
- 10Y*
- —
ASND
- 1D
- 4.64%
- 1M
- -3.42%
- YTD
- 11.89%
- 6M
- 14.03%
- 1Y
- 35.73%
- 3Y*
- 39.34%
- 5Y*
- 10.80%
- 10Y*
- 32.90%
FINV vs. ASND - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FINV FinVolution Group | -1.99% | -20.07% | 45.47% | 4.39% | 6.39% | 89.23% | 8.51% | -22.85% | -49.37% | -46.54% |
ASND Ascendis Pharma A/S | 11.89% | 54.89% | 9.31% | 3.13% | -9.22% | -19.34% | 19.88% | 122.06% | 56.39% | 13.26% |
Correlation
The correlation between FINV and ASND is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.14 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Nov 10, 2017 | 0.17 |
Fundamentals
FINV:
$1.24B
ASND:
$15.39B
FINV:
CN¥8.34
ASND:
€8.08
FINV:
3.91
ASND:
25.96
FINV:
1.37
ASND:
0.12
FINV:
0.65
ASND:
15.16
FINV:
0.52
ASND:
27.70
FINV:
CN¥13.24B
ASND:
€867.51M
FINV:
CN¥10.21B
ASND:
€764.89M
FINV:
CN¥2.61B
ASND:
-€6.94M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FINV vs. ASND — Risk / Return Rank
FINV
ASND
FINV vs. ASND - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for FinVolution Group (FINV) and Ascendis Pharma A/S (ASND). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| FINV | ASND | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.91 | ||
| Sortino ratioReturn per unit of downside risk | -2.91 | ||
| Omega ratioGain probability vs. loss probability | 0.84 | 1.19 | -0.35 |
| Calmar ratioReturn relative to maximum drawdown | -0.81 | 2.07 | -2.87 |
| Martin ratioReturn relative to average drawdown | -1.07 | 6.18 | -7.26 |
Loading charts...
Drawdowns
FINV vs. ASND - Drawdown Comparison
The maximum FINV drawdown since its inception was -89.76%, which is greater than ASND's maximum drawdown of -61.72%. Use the drawdown chart below to compare losses from any high point for FINV and ASND.
Loading charts...
Drawdown Indicators
| FINV | ASND | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.76% | -61.72% | -28.04% |
Max Drawdown (1Y)Largest decline over 1 year | -56.42% | -17.62% | -38.80% |
Max Drawdown (3Y)Largest decline over 3 years | -56.42% | -29.15% | -27.27% |
Max Drawdown (5Y)Largest decline over 5 years | -69.21% | -60.46% | -8.75% |
Max Drawdown (10Y)Largest decline over 10 years | — | -61.72% | — |
Current DrawdownCurrent decline from peak | -51.64% | -4.50% | -47.14% |
Average DrawdownAverage peak-to-trough decline | -54.08% | -18.88% | -35.20% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 42.45% | 5.84% | +36.61% |
Volatility
FINV vs. ASND - Volatility Comparison
FinVolution Group (FINV) has a higher volatility of 18.84% compared to Ascendis Pharma A/S (ASND) at 14.31%. This indicates that FINV's price experiences larger fluctuations and is considered to be riskier than ASND based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FINV | ASND | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.84% | 14.31% | +4.53% |
Volatility (6M)Calculated over the trailing 6-month period | 33.57% | 28.65% | +4.92% |
Volatility (1Y)Calculated over the trailing 1-year period | 48.73% | 37.27% | +11.46% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 49.55% | 48.72% | +0.83% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 71.67% | 51.08% | +20.59% |
Dividends
FINV vs. ASND - Dividend Comparison
FINV's dividend yield for the trailing twelve months is around 6.35%, while ASND has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
ASND Ascendis Pharma A/S | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
FINV FinVolution Group | 6.35% | 5.30% | 3.49% | 4.39% | 4.13% | 3.45% | 4.49% | 7.17% |
Financials
FINV vs. ASND - Financials Comparison
This section allows you to compare key financial metrics between FinVolution Group and Ascendis Pharma A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
FINV and ASND have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
FINV has higher volatility (18.84%) compared to ASND (14.31%). In terms of maximum drawdown, FINV dropped -89.76% vs ASND's -61.72%.
ASND currently has the higher Sharpe Ratio (0.98 vs -0.94), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FINV and ASND
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer